{"denomUnitsSelected":"Participants","reportingStatus":"NOT_POSTED","timeFrame":"Baseline to study completion (approximately 6 months)","title":"Number of Subjects With Adverse Drug Reactions and Toxicities as Evaluated by NCI CTCAE v5.0 of DKN-01 600 mg +/- Paclitaxel in Patients With Recurrent Carcinosarcoma (MMMT) in Carcinosarcoma (MMMT) Patients","type":"OTHER_PRE_SPECIFIED"}